Search Results - "NOVO, Erica"
-
1
ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis
Published in International journal of molecular sciences (01-06-2019)“…Fibrogenic progression of chronic liver disease, whatever the etiology, is characterized by persistent chronic parenchymal injury, chronic activation of…”
Get full text
Journal Article -
2
Redox mechanisms in hepatic chronic wound healing and fibrogenesis
Published in Fibrogenesis & tissue repair (13-10-2008)“…Reactive oxygen species (ROS) generated within cells or, more generally, in a tissue environment, may easily turn into a source of cell and tissue injury…”
Get full text
Journal Article -
3
Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis
Published in Cells (Basel, Switzerland) (13-07-2021)“…Liver fibrosis is a potentially reversible pathophysiological event, leading to excess deposition of extracellular matrix (ECM) components and taking place as…”
Get full text
Journal Article -
4
Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease
Published in Antioxidants & redox signaling (15-06-2010)“…Epithelial to mesenchymal transition (EMT) is a fundamental process, paradigmatic of the concept of cell plasticity, that leads epithelial cells to lose their…”
Get more information
Journal Article -
5
The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis
Published in Molecular metabolism (Germany) (01-03-2024)“…The serine protease inhibitor SerpinB3 has been described as critical mediator of liver fibrosis and it has been recently proposed as an additional hepatokine…”
Get full text
Journal Article -
6
Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells
Published in Journal of hepatology (01-06-2009)“…Background/Aims Hepatic fibrogenesis, a consequence of chronic liver tissue damage, is characterized by activation of the hepatic stellate cells (HSC). Silybin…”
Get full text
Journal Article -
7
Redox mechanisms switch on hypoxia-dependent epithelial–mesenchymal transition in cancer cells
Published in Carcinogenesis (New York) (01-12-2008)“…Epithelial–mesenchymal transition (EMT) and hypoxia are considered as crucial events favouring invasion and metastasis of many cancer cells. In this study,…”
Get full text
Journal Article -
8
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis
Published in PloS one (01-03-2017)“…Non-Alcoholic Fatty Liver Disease (NAFLD) is a major form of chronic liver disease in the general population in relation to its high prevalence among…”
Get full text
Journal Article -
9
Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis
Published in Frontiers in immunology (26-02-2024)“…Metabolic dysfunction-associated steatotic liver disease (MASLD), previously non-alcoholic fatty liver disease (NAFLD), is a leading cause of chronic liver…”
Get full text
Journal Article -
10
Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data
Published in PloS one (16-09-2016)“…Tissue Angiotensin II (Ang-II), produced through local non ACE-dependent pathways, stimulates liver fibrogenesis, renal vasoconstriction and sodium retention…”
Get full text
Journal Article -
11
Hepatic Myofibroblasts: A Heterogeneous and Redox-Modulated Cell Population in Liver Fibrogenesis
Published in Antioxidants (28-06-2022)“…During chronic liver disease (CLD) progression, hepatic myofibroblasts (MFs) represent a unique cellular phenotype that plays a critical role in driving liver…”
Get full text
Journal Article -
12
SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease
Published in Frontiers in immunology (08-07-2022)“…Non-alcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease worldwide. In 20-30% of patients, NAFLD can progress into…”
Get full text
Journal Article -
13
The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells
Published in The Journal of pathology (01-03-2012)“…Liver fibrogenesis is sustained by pro‐fibrogenic myofibroblast‐like cells (MFs), mainly originating from activated hepatic stellate cells (HSC/MFs) or portal…”
Get full text
Journal Article -
14
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells
Published in Hepatology (Baltimore, Md.) (01-12-2005)“…Leptin upregulates collagen expression in hepatic stellate cells (HSCs), but the possible modulation of other actions has not been elucidated. The aim of this…”
Get full text
Journal Article -
15
SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells
Published in Scientific reports (13-06-2017)“…SerpinB3 is a hypoxia- and hypoxia-inducible factor-2α-dependent cystein protease inhibitor that is up-regulated in hepatocellular carcinoma and in parenchymal…”
Get full text
Journal Article -
16
Curcumin limits the fibrogenic evolution of experimental steatohepatitis
Published in Laboratory investigation (01-01-2010)“…Nonalcoholic steatohepatitis is characterized by the association of steatosis with hepatic cell injury, lobular inflammation and fibrosis. Curcumin is known…”
Get full text
Journal Article -
17
Hypoxia,angiogenesis and liver fibrogenesis in the progression of chronic liver diseases
Published in World journal of gastroenterology : WJG (21-01-2010)“…Angiogenesis is a dynamic,hypoxia-stimulated and growth factor-dependent process,and is currently referred to as the formation of new vessels from preexisting…”
Get full text
Journal Article -
18
Hyperdynamic circulatory syndrome in a mouse model transgenic for SerpinB3
Published in Annals of hepatology (01-01-2020)“…SerpinB3 is a cysteine protease inhibitor involved in several biological activities. It is progressively expressed in chronic liver disease, but not in normal…”
Get full text
Journal Article -
19
n-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis
Published in Liver international (01-07-2014)“…Background & Aims n‐3 polyunsaturated fatty acids (PUFA) ameliorate fatty liver in experimental models, but their effects on inflammation and fibrosis during…”
Get full text
Journal Article -
20
Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis
Published in World journal of gastroenterology : WJG (28-08-2005)“…AIM: To investigate the effects of troglitazone (TGZ), an anti-diabetic drug which activates peroxisome proliferatoractivated receptor-y (PPAR-y), for liver…”
Get full text
Journal Article